#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial amyotrophic lateral sclerosis Gastrooesophageal cancer Gaucher's disease type I Thromboangiitis obliterans Spinal muscular atrophy Congenital nephrogenic diabetes insipidus Ureteric cancer Myxoid liposarcoma Congenital leptin deficiency Anal squamous cell carcinoma Cortical dysplasia HER2 gene amplification Dedifferentiated liposarcoma Penile squamous cell carcinoma Kawasaki's disease More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Trials in Disease Mucous membrane pemphigoid – Diagnostics Mantle cell lymphoma stage II – Basic Information Idiopathic pulmonary fibrosis – Basic Information Osteosarcoma metastatic – Life with Disease Ehlers-Danlos syndrome – Basic Information Breast angiosarcoma – Treatment Leiomyosarcoma – Treatment Leiomyosarcoma metastatic – Diagnostics Rosai-Dorfman syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Colestyramine Tipapkinogene Sovacivec Trametinib Dimethyl Sulfoxide Abt-494 TALADEGIB Nomegestrol Acetate Amylase Caplacizumab Clenbuterol Hydrochloride Sufentanil Citrate Biotin Imifoplatin TRONTINEMAB Rbl005.3 Glibenclamide Vesleteplirsen Tetracaine Hydrochloride VTX2735 SODIUM Estradiol Hemihydrate Gd2Il18Cart More therapies…

    Learn about Your Condition

    Aortic disorder Pulmonary vascular disorder Cartilage injury Acute HIV infection Hepatobiliary cancer Undifferentiated sarcoma Endometrial cancer stage II Diabetes mellitus Procedural anxiety Syphilis Chronic hepatitis C Papulopustular rosacea Onychomycosis Mantle cell lymphoma Multifocal motor neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Intradialytic Parenteral Nutrition for Muscle Protein Production in Patients on Long-term Hemodialysis Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    Investigated Drugs:
    • ARGININE GLUTAMATE
    • Aspartic Acid
    • Histidine Hydrochloride Monohydrate
    The Netherlands

  • Evaluation of Lung Function Using Xenon Gas with CT Imaging in Lung and Breast Cancer Patients Receiving Radiotherapy

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Breast cancer
    Investigated Drugs:
    • XENON (133XE)
    Belgium

  • A Study of Doravirine for Early Treatment of West Nile Virus Infection in Patients at Risk of Disease Worsening

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Doravirine
    Italy

  • Study Using Gallium-68 FAPI PET/MRI Imaging to Measure Disease Activity in Patients with Graves’ Eye Disease

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands

  • Study of dexmedetomidine compared to midazolam to reduce delirium in critically ill children on breathing machines in intensive care

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexmedetomidine
    • Midazolam
    France

  • Study of gallium-68 FAPI imaging to assess blood vessel changes in patients with pulmonary arterial hypertension receiving sotatercept

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Human Albumin As Macroaggregates
    • Sotatercept
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France
Previous Page
1 … 761 762 763 764 765 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!